Generated by GPT-5-mini| Calman–Hine report | |
|---|---|
| Name | Calman–Hine report |
| Date | 1995 |
| Authors | John Calman; Mike Hine |
| Jurisdiction | United Kingdom |
| Subject | Cancer services |
Calman–Hine report The Calman–Hine report was a 1995 United Kingdom policy review that restructured cancer services, aiming to improve outcomes by recommending specialised care pathways and multidisciplinary teams. Chaired by John Calman and Mike Hine, the report influenced National Health Service reorganisation, professional standards, hospital networks, and subsequent guidance from bodies such as the Department of Health, National Health Service Executive, and Royal Colleges. It prompted changes that linked clinical practice, medical education, and health administration across institutions like NHS trusts, cancer registries, and specialist centres.
The review was commissioned by the Department of Health and the Scottish Office amid concerns voiced by the Royal College of Physicians, Royal College of Surgeons, Royal College of Radiologists, Institute of Cancer Research, and the Macmillan Cancer Support charity, following audits from regional cancer registrys and analyses by the National Audit Office. Influences included international reports from the World Health Organization and comparative models in France, Sweden, and United States. Key individuals involved beyond the chairs included advisors from the Medical Research Council, representatives from the British Medical Association, and clinicians from teaching hospitals affiliated with University of Oxford, University of Cambridge, King's College London, and University of Edinburgh. Press coverage from outlets such as the BBC, The Guardian, and The Times heightened political attention from ministers in Downing Street and debates in the House of Commons.
The report advocated establishing defined roles for local units, cancer units, and specialist cancer centres, aligning with accreditation frameworks from the Royal College of Physicians and clinical governance frameworks promoted by the NHS Executive. It promoted multidisciplinary team (MDT) meetings involving oncologists from the Royal College of Radiologists, surgeons from the Royal College of Surgeons, pathologists from the Royal College of Pathologists, radiographers, and specialist nurses represented by the Royal College of Nursing. The review urged development of explicit referral pathways between district general hospitals such as St Thomas' Hospital and specialist centres including Royal Marsden Hospital and Christie Hospital, supported by performance indicators monitored by regional offices like the Strategic Health Authority and data from the Office for National Statistics. Training recommendations referenced curricula from General Medical Council and postgraduate bodies including the Joint Committee on Higher Medical Training.
Implementation involved directives from the Department of Health, commissioning changes within NHS trusts, and formation of cancer networks overseen by the National Cancer Action Team and later by the National Institute for Health and Care Excellence. Resource allocation drew on capital investment programmes and workforce planning influenced by the Health and Social Care Act 1999 and subsequent white papers. Measured impacts appeared in survival statistics compiled by the Office for National Statistics and epidemiological analyses from the Cancer Research UK and International Agency for Research on Cancer. Service redesigns affected institutions including Guy's Hospital, Addenbrooke's Hospital, Royal Victoria Infirmary, and led to formal MDTs at centres such as Beatson West of Scotland Cancer Centre and Mount Vernon Hospital.
Professional bodies Royal College of Surgeons and Royal College of Radiologists largely welcomed the emphasis on specialist practice, while some regional health authorities and clinicians cited implementation challenges similar to debates involving the British Medical Association and trade unions. Patient organisations including Macmillan Cancer Support and Cancer Research UK noted benefits but highlighted concerns raised by campaigners such as those associated with CancerBACUP about access inequalities in rural areas like Highlands and Islands and urban districts including Inner London. Academic critiques in journals tied to King's College London and London School of Hygiene and Tropical Medicine examined variances in outcomes echoed in international comparisons with United States, Australia, and Scotland studies, and debates linked to funding changes after legislation such as the Health and Social Care Act 2012. Concerns were also raised by policymakers in Welsh Government and Northern Ireland Assembly regarding devolution and regional implementation.
The report established concepts later embedded in national strategies from National Health Service leadership and guidance from National Institute for Health and Care Excellence and the Department of Health and Social Care. Its emphasis on MDTs, specialist centres, and referral pathways influenced curricula at universities including University College London and professional standards by the General Medical Council. International health agencies such as the World Health Organization and the Organisation for Economic Co-operation and Development referenced the model in comparative health system analyses, while charities like Marie Curie Cancer Care and Cancer Research UK continued advocacy based on its framework. Long-term effects include formation of cancer networks, accreditation processes at specialist centres like Royal Marsden Hospital, and persistent policy discussion in bodies such as the House of Commons Health Select Committee and reviews by the National Audit Office.
Category:Cancer in the United Kingdom